Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging

Part of paid clinical trials in San Diego, California.

Sponsor
Goldman, Butterwick, Fitzpatrick and Groff
Study ID
NCT07216352
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Laxity; Skin

Eligibility Criteria

Sex
ALL
Age
25 Years - 50 Years
Healthy Volunteers
Accepted

Interventions

  • AGE Serum — OTHER
    AGE serum is a topical that contains a high concentration of 30% Proxylane and a synergistic blend of fruit-derived flavonoids (blueberry, pomegranate) and Cassia alata extract.

Study Details

The primary objective is to evaluate the safety and efficacy of a topical serum (AGE serum) in improving visible signs of aging (e.g., fine lines, wrinkles, sagging, texture, radiance) on the full face and neck.The study will be conducted in non-menopausal female and male subjects who are on glucagon-like peptide-1 (GLP-1) agonist therapy for weight loss.

Key Dates

Start date
Oct 25, 2025
Status verified
Oct 2025
Primary completion
Mar 30, 2026
Completion
May 30, 2026

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: AGE Product
    Enrolled subjects will received AGE Serum.

Primary Outcome Measure

Modified Griffith Scale [ Time Frame: Baseline, Week 6 and Week12 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
West Dermatology Research CenterSan DiegoCalifornia92121
Andrea Pacheco
[email protected]
858-657-1004
Freia Canals-Cistero
858-657-1004

Find similar trials in San Diego, CA

By research site
West Dermatology Research Center· San Diego, CA

Related Studies